cmAngio® vs syngo.CT CaScoring

Similar category, different focus. These tools serve overlapping but distinct needs. Comparability 70/100 Comparability is an AI-graded 0–100 score of how directly these two tools compete — higher means a more apples-to-apples comparison.
by CureMetrix
VS
by Siemens Medical Solutions USA

AI Verdict

These tools are adjacent in their goal of leveraging AI for cardiovascular risk assessment. cmAngio® focuses on detecting Breast Arterial Calcifications (BAC) on mammograms, providing insights relevant to women's health. In contrast, syngo.CT CaScoring quantifies calcified coronary lesions from CT scans, offering detailed scoring for broader cardiovascular risk assessment.

Choose cmAngio® if…

Choose cmAngio® if your primary objective is to leverage routine mammography exams for early, non-invasive cardiovascular risk assessment in women. This AI software is ideal for detecting Breast Arterial Calcifications (BAC) on both FFDM and DBT images, providing insights into cardiovascular health without requiring additional radiation or procedures. It integrates seamlessly with existing DICOM-compliant viewers to enhance reporting capabilities.

View cmAngio® →

Choose syngo.CT CaScoring if…

Choose syngo.CT CaScoring if you need precise quantification and detailed visualization of calcified coronary lesions from dedicated CT scans. This tool is best suited for comprehensive cardiovascular risk stratification, offering calculations such as the Agatston Score, volume, and calcium mass, along with automatic highlighting of coronary calcifications. It is designed to integrate with Siemens CT scanner systems for streamlined cardiac imaging workflows.

View syngo.CT CaScoring →

Reviewed by Pouyan Golshani, MD — Interventional Radiologist

Quick Comparison

Feature cmAngio® syngo.CT CaScoring
Pricing Paid, out-of-pocket Contact for pricing
Deployment Cloud-based, integrates with any DICOM-compliant viewer Integrated with Siemens CT scanner systems; operates as a post-processing application on the multi-user syngo.via client/server platform.
FDA Status Cleared AI-estimated Cleared AI-estimated
HIPAA Yes AI-estimated Unknown

Feature-by-Feature

Detail beyond the Quick Comparison summary. For pricing, deployment, BAA, FDA, and HIPAA see the Overview tab.

Feature cmAngio® syngo.CT CaScoring
Name cmAngiou00ae syngo.CT CaScoring
Company CureMetrix Siemens Medical Solutions USA
Primary Use/Description FDA-cleared AI software for detecting Breast Arterial Calcifications (BAC) on mammograms, providing insights into cardiovascular health and aiding early risk assessment. AI-powered image analysis software for quick quantification and accurate visualization of calcified coronary lesions from CT scans, aiding in cardiovascular risk assessment and documentation.
Target Condition/Anatomy Breast Arterial Calcifications (BAC) on mammograms Calcified coronary lesions from CT scans
Input Imaging Modality Full-Field Digital Mammography (FFDM) and Digital Breast Tomosynthesis (DBT) exams CT scans
Key Output Metrics/Scores Visualization of BAC location on a scorecard, BAC identification and reporting. Agatston Score, volume, calcium mass, plaque burden (total and per coronary artery), 'Coronary Age'.

Videos

Demos, reviews, and walkthroughs featuring cmAngio® and syngo.CT CaScoring.

Loading videos…
Videos need JavaScript to load. Search YouTube directly →

View all on YouTube

Frequently Asked Questions

cmAngiou00ae by CureMetrix is designed to detect Breast Arterial Calcifications (BAC) on mammograms, including both Full-Field Digital Mammography (FFDM) and Digital Breast Tomosynthesis (DBT) exams. In contrast, syngo.CT CaScoring by Siemens Medical Solutions USA is an AI-powered software for quantifying calcified coronary lesions from CT scans.
cmAngiou00ae provides visualization of BAC location on a scorecard, enabling identification and reporting of these incidental findings. syngo.CT CaScoring offers more detailed quantification, calculating the Agatston Score, volume, and calcium mass, and assessing plaque burden in total and per coronary artery.
cmAngiou00ae provides insights into cardiovascular health and aids early risk assessment by detecting BAC on mammograms, which are considered an incidental finding indicative of arteriosclerosis. syngo.CT CaScoring focuses on quantifying calcified coronary lesions from CT scans, which is used as a prognostic indicator of a patient's risk of morbidity from atherosclerotic coronary heart disease and can be compared to healthy reference groups.
cmAngiou00ae boasts quick and easy installation, typically taking less than an hour. In contrast, syngo.CT CaScoring is integrated with Siemens CT scanner systems and functions as a post-processing application within the syngo.via platform, implying a more integrated setup within existing Siemens infrastructure.

Backers

Who funded each tool's parent company.

cmAngio®

AI Tool Finder
AI-powered search. Results may not be comprehensive.